Studies found that TRIM38 expression was significantly increased in peripheral blood mononuclear cells (PBMCs) of HBeAg-negative chronic hepatitis B patients, suggesting a potential association with the early treatment effects of peg-IFN-α and HBsAg clearance [15]. Here, TRIM38 is linked to chronic hepatitis B virus infection.